Ovarian Cancer Research Alliance (OCRA) is currently accepting applications for its Rivkin Pilot Grant 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About OCRA Rivkin Pilot Grant
The OCRA Rivkin Pilot Grant is designed to fund innovative, high-risk, high-reward research that generates preliminary data, tests feasibility, and strengthens investigators’ ability to secure future external funding. The programme focuses on projects directly relevant to ovarian and related gynecologic cancers, supporting work with translational significance that can lead to meaningful clinical or scientific outcomes.
Benefits of OCRA Rivkin Pilot Grant
- Support of up to $50,000 USD annually for two years ($100,000 USD total) will be granted to the institution of the Principal Investigator.
OCRA Rivkin Pilot Grant Requirements
1. Researcher Requirements
- Principal Investigators at all stages of their careers are eligible to apply. Applicants must have either their PhD, ScD, MD or other doctoral degree at the time of application.
- There are no citizenship requirements for OCRA Grants; international applicants are welcome to apply.
2. Proposed Research Project Requirements:
- Research projects should be innovative and multidisciplinary, designed to test feasibility, generate preliminary data, and demonstrate strong potential for subsequent external funding, with clear translational relevance.
- Analysis of data from previously funded clinical trials will be considered if it advances a novel hypothesis or generates proof-of-concept findings.
- Projects must focus on ovarian cancer or demonstrate clear, direct relevance to ovarian cancer, including work in related gynecologic cancers.
3. Institutional Eligibility and Applicant Limits:
- Funding is limited to accredited academic institutions (e.g., universities and colleges) and other eligible research institutions, provided they are non-profit, including research hospitals, research institutes, and recognized scientific research facilities. OCRA does not provide funding to for-profit entities, consulting companies, non-research organizations, or non-profits that are not conducting the research themselves.
- An individual may serve as Principal Investigator (PI) on only one Letter of Intent (LOI) per grant cycle. This limit applies across all grant opportunities within the same cycle. Individuals may participate in additional LOIs but only in a non-PI role.
- A PI may hold only one active OCRA grant at a time. If a PI has an active OCRA grant, it must conclude before a new grant may begin.
4. Review Considerations:
- Applications will be evaluated based on scientific merit, originality, and relevance to ovarian cancer and/or related gynecologic cancers.
- Reviewers will also assess the likelihood that this funding will enable investigators to build or strengthen a research team capable of conducting high-impact research and successfully competing for future external funding.
Application Date and Process
- Letters of Intent must be submitted in English via SmartSimple: https://ocra.us-1.smartsimple.com/ by 5:00 PM ET on March 25, 2026.
- The Letter of Intent must be submitted through the Principal Investigator’s (PI’s) SmartSimple account. The individual logged into SmartSimple when the LOI is created will automatically be designated as the PI.
- Applicants are encouraged to log into SmartSimple early to review system requirements.
Application Deadline
25 March, 2026
Opportunity Application
View details of
OCRA Rivkin Pilot Grant
Apply for OCRA Rivkin Pilot Grant
🔍
